These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32761364)

  • 1. Achilles tendon thickening is associated with higher incidence of adverse cardiovascular event in patients with coronary artery disease.
    Hashimoto T; Minami Y; Asakura K; Katamine M; Kato A; Katsura A; Sato T; Muramatsu Y; Kakizaki R; Fujiyoshi K; Ishida K; Kameda R; Meguro K; Shimohama T; Ako J
    Heart Vessels; 2021 Feb; 36(2):163-169. PubMed ID: 32761364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achilles Tendon Thickening as a Risk Factor of Cardiovascular Events after Percutaneous Coronary Intervention.
    Matsumoto I; Kurozumi M; Namba T; Takagi Y
    J Atheroscler Thromb; 2023 May; 30(5):491-501. PubMed ID: 35850983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achilles tendon thickening is associated with disease severity and plaque vulnerability in patients with coronary artery disease.
    Hashimoto T; Minami Y; Kakizaki R; Nemoto T; Fujiyoshi K; Meguro K; Shimohama T; Tojo T; Ako J
    J Clin Lipidol; 2019; 13(1):194-200. PubMed ID: 30472278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of Achilles tendon thickness in elderly patients after percutaneous coronary intervention: A 5-year follow-up.
    Isawa T; Horie K; Toyoda S; Taguri M
    J Cardiol; 2023 Dec; 82(6):448-454. PubMed ID: 37506821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention.
    Kitahara H; Nakayama T; Fujimoto Y; Kobayashi Y
    J Cardiol; 2020 Jun; 75(6):654-658. PubMed ID: 31992496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achilles tendon thickness is associated with coronary lesion severity in acute coronary syndrome patients without familial hypercholesterolemia.
    Fujiwara R; Yahiro R; Horio T; Miyauchi M; Yoshimura R; Matsuoka Y; Yokouchi G; Sakamoto Y; Matsumoto N; Fukuda K; Izumiya Y; Yoshiyama M; Fujimoto K; Kasayuki N
    J Cardiol; 2022 Feb; 79(2):311-317. PubMed ID: 34657775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Kitahara H; Mori N; Saito Y; Nakayama T; Fujimoto Y; Kobayashi Y
    Heart Vessels; 2019 Oct; 34(10):1595-1599. PubMed ID: 30968218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mutations, regression of Achilles tendon thickness, and cardiovascular events among patients with familial hypercholesterolemia.
    Tada H; Okada H; Nohara A; Takamura M; Kawashiri MA
    Atherosclerosis; 2022 Jan; 340():28-34. PubMed ID: 34871818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
    Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T
    Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of changes in Achilles tendon thickening on cardiovascular events in patients with familial hypercholesterolemia.
    Tada H; Kojima N; Takeji Y; Nohara A; Kawashiri MA; Takamura M
    Am J Prev Cardiol; 2024 Jun; 18():100660. PubMed ID: 38590629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of lipid core plaque in patients with Achilles tendon xanthoma undergoing percutaneous coronary intervention for coronary artery disease.
    Kitahara H; Yamazaki T; Hiraga T; Yamashita D; Matsumoto T; Kobayashi T; Sato T; Suzuki M; Saito K; Matsuoka T; Mori N; Tateishi K; Fujimoto Y; Kobayashi Y
    J Cardiol; 2022 Apr; 79(4):559-563. PubMed ID: 34895790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia.
    Wang B; Zhang Q; Lin L; Pan LL; He CY; Wan XX; Zheng ZA; Huang ZX; Zou CB; Fu MC; Kutryk MJ
    Lipids Health Dis; 2018 Jun; 17(1):131. PubMed ID: 29859112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
    Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of complete revascularization in elderly patients with multi-vessel coronary artery disease undergoing percutaneous coronary intervention: A sub-analysis of the SHINANO registry.
    Harada M; Miura T; Kobayashi T; Kobayashi H; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eisawa T; Hashizume N; Ebisawa S; Miyashita Y; Ikeda U;
    Int J Cardiol; 2017 Mar; 230():413-419. PubMed ID: 28040276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Roumeliotis A; Claessen B; Dangas G; Torguson R; Sartori S; Reisman A; Cao D; Chandiramani R; Nicolas J; Goel R; Chiarito M; Sharma M; Bandyopadhyay D; Baber U; Sweeny J; Barman N; Sharma S; Kini A; Mehran R
    Am J Cardiol; 2020 Dec; 137():1-6. PubMed ID: 33002465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of nutritional status assessed by the Controlling Nutritional Status score in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Wada H; Dohi T; Miyauchi K; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Clin Res Cardiol; 2017 Nov; 106(11):875-883. PubMed ID: 28634674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2.
    Morikami Y; Natsuaki M; Morimoto T; Ono K; Nakagawa Y; Furukawa Y; Sakata R; Aota M; Okada Y; Onoe M; Kawasuji M; Koshiji T; Nakajima H; Nishizawa J; Yamanaka K; Yamamoto H; Kimura T;
    Atherosclerosis; 2013 Jun; 228(2):426-31. PubMed ID: 23623262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of serum albumin levels on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Heart Vessels; 2017 Sep; 32(9):1085-1092. PubMed ID: 28429111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population.
    Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Coron Artery Dis; 2017 Jun; 28(4):307-314. PubMed ID: 28272162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.